Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Ravkilde

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 21, 2012
Sex- and age-related differences in clinical outcome after primary percutaneous coronary interventionLars Jakobsen, Troels Niemann, Niels Thorsgaard, et al.
Circulation. Cardiovascular Interventions|April 10, 2014
Prevention of contrast-induced nephropathy with N-acetylcysteine or sodium bicarbonate in patients with ST-segment-myocardial infarction: a prospective, randomized, open-labeled trialPer Thayssen, Jens Flensted Lassen, Svend Eggert Jensen, et al.
BMC Cardiovascular Disorders|March 21, 2012
Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy)Troels Thim, Michael Maeng, Jens Flensted Lassen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 15, 2010
Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart RegistryLisette Okkels Jensen, Hans Henrik Tilsted, Per Thayssen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 11, 2013
Outcomes after revascularisation with everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes and stable angina pectoris: a substudy of the SORT OUT IV trialLisbeth Antonsen, Per Thayssen, Henrik S Hansen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 16, 2017
Denmark: coronary and structural heart interventions from 2010 to 2015Hans-Henrik Tilsted, Ole Ahlehoff, Christian J Terkelsen, et al.
European Journal of Clinical Investigation|May 26, 2012
Zotarolimus-eluting vs. sirolimus-eluting coronary stents in patients with and without acute coronary syndromes: a SORT OUT III substudyTroels Thim, Michael Maeng, Anne Kaltoft, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 22, 2012
The risk and prognostic impact of definite stent thrombosis or in-stent restenosis after coronary stent implantationPer Thayssen, Lisette Okkels Jensen, Jens Flensted Lassen, et al.
Journal of the American College of Cardiology|February 20, 2016
Safety and Efficacy of Everolimus- Versus Sirolimus-Eluting Stents: 5-Year Results From SORT OUT IVLisette Okkels Jensen, Per Thayssen, Evald Høj Christiansen, et al.
The American Journal of Cardiology|December 16, 2014
Long-term outcome of sirolimus-eluting and zotarolimus-eluting coronary stent implantation in patients with and without diabetes mellitus (a Danish organization for randomized trials on clinical outcome III substudy)Kevin K W Olesen, Hans-Henrik Tilsted, Lisette O Jensen, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 21, 2012
Sex- and age-related differences in clinical outcome after primary percutaneous coronary interventionLars Jakobsen, Troels Niemann, Niels Thorsgaard, et al.
Circulation. Cardiovascular Interventions|April 10, 2014
Prevention of contrast-induced nephropathy with N-acetylcysteine or sodium bicarbonate in patients with ST-segment-myocardial infarction: a prospective, randomized, open-labeled trialPer Thayssen, Jens Flensted Lassen, Svend Eggert Jensen, et al.
BMC Cardiovascular Disorders|March 21, 2012
Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy)Troels Thim, Michael Maeng, Jens Flensted Lassen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 15, 2010
Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart RegistryLisette Okkels Jensen, Hans Henrik Tilsted, Per Thayssen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 11, 2013
Outcomes after revascularisation with everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes and stable angina pectoris: a substudy of the SORT OUT IV trialLisbeth Antonsen, Per Thayssen, Henrik S Hansen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 16, 2017
Denmark: coronary and structural heart interventions from 2010 to 2015Hans-Henrik Tilsted, Ole Ahlehoff, Christian J Terkelsen, et al.
European Journal of Clinical Investigation|May 26, 2012
Zotarolimus-eluting vs. sirolimus-eluting coronary stents in patients with and without acute coronary syndromes: a SORT OUT III substudyTroels Thim, Michael Maeng, Anne Kaltoft, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 22, 2012
The risk and prognostic impact of definite stent thrombosis or in-stent restenosis after coronary stent implantationPer Thayssen, Lisette Okkels Jensen, Jens Flensted Lassen, et al.
Journal of the American College of Cardiology|February 20, 2016
Safety and Efficacy of Everolimus- Versus Sirolimus-Eluting Stents: 5-Year Results From SORT OUT IVLisette Okkels Jensen, Per Thayssen, Evald Høj Christiansen, et al.
The American Journal of Cardiology|December 16, 2014
Long-term outcome of sirolimus-eluting and zotarolimus-eluting coronary stent implantation in patients with and without diabetes mellitus (a Danish organization for randomized trials on clinical outcome III substudy)Kevin K W Olesen, Hans-Henrik Tilsted, Lisette O Jensen, et al.
Pageof 9